Number | Percent | |
---|---|---|
Clinical manifestations | 102 | 82.9 |
SpO2 monitoring | 82 | 66.7 |
PHOX2B gene mutation test | 74 | 60.2 |
Blood gas analysis | 62 | 50.4 |
Ventilatory response to CO2 | 24 | 19.5 |
End-tidal CO2 | 16 | 13.0 |
Tidal volume monitoring | 9 | 7.3 |
Percutaneous CO2 monitoring | 2 | 1.6 |
Clinical manifestations + SpO2 monitoring | 71 | 57.7 |
Clinical manifestations + Blood gas analysis | 59 | 48.0 |
Clinical manifestations + Ventilatory response to CO2 | 20 | 16.2 |